Protocol for ecotropic pseudotyped lentiviral transduction of “murinized” human cells while decreasing risk of infection for laboratory personnel
Year: 2025
Type: article
Abstract: Lentiviral systems of transduction are valuable tools to stably express transgenes of interest in human cell lines. However, their use risks infection of the lab workers. Here, we present a protocol for lentiviral vector system pseudotyping with the murine ecotropic envelope. We detail steps for producing ecotropic pseudotyped lentiviral particles and transiently expressing the Slc7a1 receptor for murine leukemia virus in target human cells. We then describe procedures for puromycin selection and the characterization of stable cell lines for transgene expression. For complete details on the use and execution of this protocol, please refer to Iyer-Bierhoff et al. 1 • Steps for the production of ecotropic pseudotyped lentiviral particles • Instructions for “murinizing” human target cells with the membrane receptor Slc7a1 • Guide to lentiviral transduction of “murinized” target cells • Steps for puromycin selection and characterization of stable transductants Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. Lentiviral systems of transduction are valuable tools to stably express transgenes of interest in human cell lines. However, their use risks infection of the lab workers. Here, we present a protocol for lentiviral vector system pseudotyping with the murine ecotropic envelope. We detail steps for producing ecotropic pseudotyped lentiviral particles and transiently expressing the Slc7a1 receptor for murine leukemia virus in target human cells. We then describe procedures for puromycin selection and the characterization of stable cell lines for transgene expression.
Source: STAR Protocols
Authors: Sandra L.K. Weber, Thorsten Heinzel, Aishwarya Iyer-Bierhoff
Institution: Friedrich Schiller University Jena
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,550
Funder: Carl-Zeiss-Stiftung
OpenAlex ID: W4408725293
